← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

A

$ Value

$0

Shares

150,000

Price

$0

Filed

Feb 4

Insider

Name

Savitz Ryan

Title

EVP, CFO & CBO

CIK

0001992324

Roles

Officer

Transaction Details

Transaction Date

2026-02-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

150,000

Footnotes

The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001992324-26-000002

Form Type

4

Issuer CIK

0001690585

Savitz Ryan's History

Date Ticker Type Value
2026-04-09 DNTH M $147K
2026-04-09 DNTH $739K
2026-04-09 DNTH M $0
2026-03-31 DNTH M $628K
2026-03-31 DNTH M $715K
2026-03-31 DNTH $109K
2026-03-31 DNTH $1.7M
2026-03-31 DNTH $119K
2026-03-31 DNTH $65K
2026-03-31 DNTH $196K

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
2026-02-03
Garcia Marino
CEO AND PRESIDENT
2026-02-03
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
2026-02-03
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09